Emily Poe, executive VP for healthcare at Cohn & Wolfe, has returned to W20 Group as global practice leader for healthcare communications.
Poe, a veteran healthcare communicator, spent five years at W20 before departing in 2013 as a group director for C&W.
W20 notes her client experience spans healthcare blue chips like Pfizer, Merck, Bayer and Boston Scientific. COO Jennifer Gottlieb said Poe has experience in healthcare's "biggest launches and toughest issues."
She previously held VP roles with Vox Medica, Cohn & Wolfe and Noonan/Russo Communications after starting out in the publishing realm.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
